What question did this study set out to answer?

The aim is to establish a robust quality control (QC) infrastructure for epigenomics research.

April 23, 2026Open Access

Epigenomics Meets Edge: Building a Freemium Quality Control Interface for Chromatin Research

Key Points

The aim is to establish a robust quality control (QC) infrastructure for epigenomics research.
Developed a framework integrating Nextflow and AWS HealthOmics for data processing.
Created an EpiPak Shiny dashboard for user interface and interaction.
Addressed GDPR as a design principle for data management.
Established a scalable freemium model for quality control in epigenomics.
Integrated multiple tools to enhance the efficiency and accessibility of chromatin research.
Positioned GDPR not just for compliance but as a core architectural element.

Abstract

Builds the infrastructure-before-intelligence argument for epigenomics QC. Covers Nextflow/AWS HealthOmics/Bedrock foundational phase, EpiPak Shiny dashboard architecture, freemium boundary at scale, and GDPR as architectural specification rather than compliance overhead.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Nicolas Waern (Tue,) studied this question.

synapsesocial.com/papers/69e9b89b85696592c86ebb60 https://doi.org/https://doi.org/10.5281/zenodo.19683105

Bookmark

View Full Paper